If you notice any issues or missing content, please let us know. Your feedback helps us improve. Thank you.
Principal Investigator
Dr. Dalip Kumar and Dr. Anil Kumar
Funding Agency
Ranbaxy
Type of Project
Industry
Sanction Amount (INR)
40
Status
Completed
Targeting the RNA-dependent RNA polymerase (RdRp) of SARS-COV2 for the development of inhibitors
Asymmetric synthesis of [2.2.2] azabicyclo-isoquinuclidine derivatives: Towards the synthesis of related alkaloids
This website uses cookies or similar technologies, to enhance your browsing experience.